Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Catheter Infection: later-stage trial registry
3 of 3 indexed Catheter Infection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Catheter Infection: 3 US clinical trials tracked, 3 recruiting.
Catheter Infection is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Silq Technologies Corporation, running 1 of these trials.
Enrollment posture brief
Registry condition catheter-infection
OPEN 3 | RECR 100% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Catheter Infection lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Catheter Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Catheter Infection is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Gentamicin Bladder Instillation on CAUTI
St. Joseph's Hospital and Medical Center, Phoenix
NCT06332040
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
Ohio State University
NCT07239219
Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention
Silq Technologies Corporation
NCT05931887
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Catheter Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Catheter Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Catheter Infection page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Catheter Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Silq Technologies Corporation sponsors the most Catheter Infection trials on record, review their full trial history before evaluating a specific study. See Silq Technologies Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Catheter Infection condition card totals 3 registered trials; most-linked intervention Gentamicin; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.